EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Autologous T cells targeting Epstein-Barr virus (EBV) latent membrane proteins (LMPs) have shown safety and efficacy in the treatment of patients with type 2 latency EBV-associated lymphomas for whom standard therapies have failed, including high-dose chemotherapy followed by autologous stem-cell re...

Full description

Saved in:
Bibliographic Details
Published in:Blood
Main Authors: McLaughlin, Lauren P., Rouce, Rayne, Gottschalk, Stephen, Torrano, Vicky, Carrum, George, Wu, Meng-Fen, Hoq, Fahmida, Grilley, Bambi, Marcogliese, Andrea M., Hanley, Patrick J., Gee, Adrian P., Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E., Bollard, Catherine M.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2018
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265652/
https://ncbi.nlm.nih.gov/pubmed/30262660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-07-863654
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items